Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
Department of Pediatrics, The University of Chicago, Chicago, IL, USA.
Trends Mol Med. 2021 Dec;27(12):1175-1186. doi: 10.1016/j.molmed.2021.08.002. Epub 2021 Sep 10.
Despite improvements in survival for very low birthweight (VLBW) premature infants, there continues to be significant morbidity for these infants at remarkable cost to the healthcare system. Concurrent development of the preterm infant intestine alongside the gut microbiome in the clinical setting rather than in the protected in utero environment where it would usually occur creates significant vulnerabilities for the infant's immature intestine and immune system, resulting in devastating illness and neurological injury. However, the microbiome also has the capacity to promote healthy development. Studies of parallel gut microbiome and preterm infant development have given key insight into the impact of the microbiome on intestinal as well as neural development and may provide potential therapeutic targets to prevent preterm infant morbidities.
尽管极低出生体重(VLBW)早产儿的存活率有所提高,但这些婴儿的发病率仍然很高,这给医疗保健系统带来了巨大的负担。早产儿肠道与肠道微生物组在临床环境中的同步发育,而不是在通常发生的宫内保护环境中发育,这给婴儿不成熟的肠道和免疫系统带来了巨大的脆弱性,导致严重的疾病和神经损伤。然而,微生物组也有促进健康发育的能力。对平行肠道微生物组和早产儿发育的研究深入了解了微生物组对肠道和神经发育的影响,并可能为预防早产儿发病提供潜在的治疗靶点。